Anti-pancreatic antibody in Turkish patients with inflammatory bowel disease and first-degree relatives

doi:10.3748/wjg.v16.i45.5732

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 45

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3482)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

302

HTML

2691

Figures (1-2)

257

Tables (1-5)

232

Sum=3482

Dec 7, 2010 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Dec 7, 2010; 16(45): 5732-5738
Published online Dec 7, 2010. doi: 10.3748/wjg.v16.i45.5732

Table 3 Positivity rates of pancreatic antibody according to Vienna classification

		A1 (n = 43, PAB = 7, 16.27%)				A2 (n = 21, PAB = 2, 9.52%)
		B1 (n = 31, PAB = 5, 16.12%)	B2 (n = 6, PAB = 1, 16.66%)	B3 (n = 6, PAB = 1, 16.66%)		B1 (n = 20, PAB = 2, 10%)	B2 (n = 1, PAB = 0, 0%)	B3 (n = 0, PAB = 0, 0%)
L1 (n = 26, 3.84%)	A1 (n = 18, PAB = 1, 5.55%)	n = 15, PAB = 1, 6.66%	n = 0, PAB = 0, 0%	n = 3, PAB = 0, 0%	A2 (n = 8, PAB = 0, 0%)	n = 7, PAB = 0, 0%	n = 1, PAB = 0, 0%	n = 0, PAB = 0, 0%
L2 (n = 2, 0%)	A1 (n = 1, PAB = 0, 0%)	n = 1, PAB = 0, 0%	n = 0, PAB = 0, 0%	n = 0, PAB = 0, 0%	A2 (n = 1, PAB = 0, 0%)	n = 1, PAB = 0, 0%	n = 0, PAB = 0, 0%	n = 0, PAB = 0, 0%
L3 (n = 36, 22.22%)	A1 (n = 24, PAB = 6, 25%)	n = 15, PAB = 4, 25%	n = 6, PAB = 1, 16.66%	n = 3, PAB = 1, 33.33%	A2 (n = 12, PAB = 2, 16.66%)	n = 12, PAB = 2, 16.66%	n = 0, PAB = 0, 0%	n = 0, PAB = 0, 0%

A1: Disease onset age < 40 yr; A2: Disease onset age ≥ 40 yr; B1: Inflammatory type; B2: Stricturizing type; B3: Fistulizing type; L1: Ileal involvement; L2: Colonic involvement; L3: Ileocolonic involvement. PAB: Pancreatic antibody.

Citation: Demirsoy H, Ozdil K, Ersoy O, Kesici B, Karaca C, Alkim C, Akbayir N, Erdem LK, Onuk MD, Beyzadeoglu HT. Anti-pancreatic antibody in Turkish patients with inflammatory bowel disease and first-degree relatives. World J Gastroenterol 2010; 16(45): 5732-5738
URL: https://www.wjgnet.com/1007-9327/full/v16/i45/5732.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i45.5732